MedTrace Logo

A Study of Serum Folate Levels in Patients Treated With Olaparib

NCT04024254 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-03-04

Study results available
· View outcomes & findings →

Summary

This is a study investigating folate deficiency (lack of folic acid in the blood) in patients who take the drug olaparib to treat their advanced ovarian or breast cancer.

Conditions

Interventions

DRUG

Folic Acid Tablet

Folic Acid 1 mg by mouth daily

Sponsors & Collaborators

  • Rush University Medical Center

    lead OTHER

Principal Investigators

  • Lydia Usha, MD · Rush University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-21
Primary Completion
2025-12-31
Completion
2025-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04024254 on ClinicalTrials.gov